TRACON Pharmaceuticals, Inc. (TCON)
After hours:
| Previous Close | 1.8200 |
| Open | 1.8200 |
| Bid | 1.7900 x 200 |
| Ask | 1.9100 x 200 |
| Day's Range | 1.8200 - 1.9560 |
| 52 Week Range | 1.5900 - 24.0000 |
| Volume | |
| Avg. Volume | 238,189 |
| Market Cap | 4.209M |
| Beta (5Y Monthly) | 1.04 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call Transcript
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call Transcript March 5, 2024 TRACON Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.01, expectations were $-0.03. TCON isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day ladies and gentlemen and […]
- Insider Monkey
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q3 2023 Earnings Call Transcript
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q3 2023 Earnings Call Transcript November 9, 2023 Operator: Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals Third Quarter 2023 Earnings Conference Call. [Operator Instructions] During today’s call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, regulatory activities, financing opportunities, […]
- Thomson Reuters StreetEvents
Q2 2023 TRACON Pharmaceuticals Inc Earnings Call
Q2 2023 TRACON Pharmaceuticals Inc Earnings Call
